Clinical Trials

Showing trials with last updates posted in 2026.

NCT06442475 | RECRUITING | PHASE2
20 participants

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2024-08-29
Completion:
2027-08-12
Conditions
  • Ann Arbor Stage II Follicular Lymphoma
  • Ann Arbor Stage II Marginal Zone Lymphoma
  • Ann Arbor Stage III Follicular Lymphoma
  • Ann Arbor Stage III Marginal Zone Lymphoma
  • Ann Arbor Stage IV Follicular Lymphoma
  • Ann Arbor Stage IV Marginal Zone Lymphoma
  • Grade 1 Follicular Lymphoma
  • Grade 2 Follicular Lymphoma
  • Grade 3a Follicular Lymphoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06414733 | RECRUITING | PHASE1
42 participants

HER-2 B Cell Peptide Vaccine

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2025-01-17
Completion:
2029-12-31
Conditions
  • Metastatic Breast Cancer
  • HER2-positive Breast Cancer
  • EGFR Overexpression
  • Metastatic Esophageal Carcinoma
  • HER-2 Positive Esophageal Cancer
Interventions
  • BIOLOGICAL
No Results Yet
NCT06364410 | RECRUITING | PHASE1
48 participants

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2025-02-03
Completion:
2027-07-08
Conditions
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Locally Advanced Gastric Carcinoma
  • Locally Advanced Gastroesophageal Junction Adenocarcinoma
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Gastric Carcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Gastric Carcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
  • Unresectable Malignant Solid Neoplasm
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06331546 | RECRUITING | NA
80 participants

Gut Oxalate Absorption in Calcium Oxalate Stone Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2024-04-17
Completion:
2030-12-31
Conditions
  • Kidney Stone
  • Kidney Calculi
  • Urolithiasis
  • Urolithiasis, Calcium Oxalate
  • Nephrolithiasis
  • Nephrolithiasis, Calcium Oxalate
  • Oxalate Urolithiasis
  • Oxaluria
  • Healthy
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT06330246 | RECRUITING | NA
40 participants

O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2024-04-17
Completion:
2030-12-31
Conditions
  • Kidney Stone
  • Kidney Calculi
  • Urolithiasis
  • Urolithiasis, Calcium Oxalate
  • Nephrolithiasis
  • Nephrolithiasis, Calcium Oxalate
  • Oxalate Urolithiasis
  • Oxaluria
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT06259409 | ACTIVE_NOT_RECRUITING | PHASE1
30 participants

Regenn® Therapy System Safety Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2024-10-09
Completion:
2026-12-31
Conditions
  • Surgical Wound
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page